首页> 中国专利> 一种治桥本氏病的中药组方

一种治桥本氏病的中药组方

页面导航

摘要
著录项
相似文献

摘要

一种治桥本氏病的中药组方，包括如下重量份数的物质：黄芪110‑130份、当归90‑110份、茯苓60‑80份、白术30‑50份、女贞子50‑70份、白芍50‑70份、玉竹30‑50份、知母40‑60份、天冬50‑70份、玄参40‑60份、远志50‑70份、夏枯草50‑70份、玫瑰花30‑50份、山茱萸40‑60份、生地40‑60份、琥珀20‑40份、合欢皮40‑60份、天葵子40‑60份、天竺黄50‑70份、山茱萸40‑60份、何首乌30‑50份。本发明紧和病机所在使药定位在甲状腺部位，经过经络走行特点调整冲任二脉，纠正肝木失养，而调补脾胃阳气、养心安神、化痰和中则一方统之。以上方剂经病人的大量使用已获得显著的疗效，在应用中尚未发现任何毒副作用，总之该方新起点，效力专宏，可以直达病所，又具有适应性广泛之优点。

著录项

公开/公告号CN113425811A

专利类型发明专利
公开/公告日2021-09-24

原文格式PDF
申请/专利权人莱州市探索医疗科技有限公司;
展开▼

申请/专利号CN202110834030.2
发明设计人姜洪敏;姜伟;
展开▼

申请日2021-07-23
分类号A61K36/899(20060101);
代理机构37307 济南尚本知识产权代理事务所(普通合伙);
代理人张晓瑾
地址 261400 山东省烟台市莱州市永安路街道北苑路317号101-4室
入库时间 2023-06-19 12:43:46

相似文献

专利
中文文献
外文文献

1. 一种治桥本氏病的中药组方 [P] . 中国专利： CN113425811A . 2021-09-24
2. 一种治疗桥本氏病的药物组合物及其制备方法 [P] . 中国专利： CN105435197A . 2016-03-30
3. compound, pharmaceutical composition, method of selective activation/stimulation of nicotinic receptors from to-7 in a patient in which such activation/stimulation has a therapeutic effect, method of treating a patient suffering from a psychotic disease, a neurodegenerative disease involving a dysfunction of the cholinergic system, and/or a condition of impaired memory and/or cognition, method of treatment of a patient suffering from dementia and/or another condition with memory loss, method of treatment of a patient suffering from memory impairment due to mild cognitive impairment due to aging, alzheimer's malady,schizophrenia, parkinson malady, huntington malady, pick malady, creutzfeldt-jakob malady, depression, aging, head trauma, stroke, snc hypoxia, cerebral senility, multiinfarction dementia, HIV and/or cardiovascular disease, method of treatment and/or prevention of dementia in a patient with alzheimer's disease, method of treating a patient to cut off the alcohol vein or treat [P] . BRPI0517494A . 2008-10-14

机译：化合物，药物组合物，在其中这种激活/刺激具有治疗作用的患者中选择性激活/刺激烟碱受体从to-7的方法，治疗患有精神病，涉及神经功能障碍的神经退行性疾病的患者的方法胆碱能系统和/或记忆力和/或认知障碍的状况，患有痴呆症的患者的治疗方法和/或患有记忆力丧失的另一种状况，由于轻度认知障碍而遭受记忆力障碍的患者的治疗方法由于衰老，阿尔茨海默氏病，精神分裂症，帕金森氏病，亨廷顿氏病，匹克病，creutzfeldt-jakob病，抑郁症，衰老，头部外伤，中风，snc缺氧，脑衰老，多发性梗塞性痴呆，HIV和/或心血管疾病，治疗方法治疗和/或预防老年痴呆症患者的痴呆症，治疗患者的方法以切断酒精静脉或治疗
4. Processes for detecting the presence of alzheimer's disease and mitochondrial origin in an individual and the genetic mutations that cause alzheimer's disease to inhibit the transcription or translation of genes and one or more nucleic acids encoding a mutant cytochrome c oxidase to selectively introduce a conjugated molecule in mitochondria to build a cell line to evaluate a compound for potential utility in the diagnosis of disorders in the treatment of a disorder and in the diagnosis or treatment of diabetes mellitus to prepare a cibrid animal and to determine the presence of a human disease of origin mitochondrial isolated nucleotide sequences probe kit therapeutic composition ribozyme cell line and animal hybrid [P] . BR9507241A . 1997-09-16

机译：用于检测个体中阿尔茨海默氏病和线粒体起源的存在的方法以及导致阿尔茨海默氏病抑制基因和一种或多种编码突变型细胞色素C氧化酶的核酸的转录或翻译的遗传突变，以选择性地将共轭分子引入线粒体建立一种细胞系，以评估该化合物在疾病诊断，疾病治疗以及糖尿病的诊断或治疗中的潜在效用，从而制备出纤巧的动物并确定是否存在人源性线粒体疾病核苷酸序列探针试剂盒治疗组合物核酶细胞系和动物杂种
5. Compounds, pharmaceutical composition and uses of compounds or pharmacologically acceptable salts or esters of prodrogas or preparations of the same, and methods of preparation of pharmacologically acceptable salts of the compounds, inhibition of one or more enzymes oxidase of improvement of funu00c7 Cognitive preparation, treatment of deterioration of memory, cognitive deterioration, soft.The Alzheimer's disease or Alzheimer's disease, Parkinson's disease or the associated with the age, treatment of disorder psiquiu00c1trica and treatment of deterioration of memory in an animal. [P] . BRPI0815694A2 . 2014-09-30

机译：化合物，药物组合物和前药的药理学上可接受的盐或酯或它们的制剂的用途，以及该化合物的药理学上可接受的盐的制备方法，一种或多种酶氧化酶的抑制，以改善认知功能，记忆力减退，认知能力减退，软性的治疗。阿尔茨海默氏病或阿尔茨海默氏病，帕金森氏病或与年龄有关的疾病，psiqui紊乱的治疗以及动物记忆力的降低。